/
OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.
Mentions
1 mention · latest on 1 Jan 2025
See which tracked investors hold OnKure Therapeutics, Inc. →Ownership and position changes on OwnershipTrace
| Generals and WorkoutsBlog | 2024 Portfolio Review | - | 1 Jan 2025 |